News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aegerion Pharmaceuticals, Inc. Announces Participation at Jefferies and Co. 2012 Global Healthcare Conference



5/30/2012 9:14:37 AM

CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Jefferies 2012 Global Healthcare Conference in New York City. Marc D. Beer, CEO of Aegerion, is scheduled to present on Wednesday, June 6, 2012 at 8:30 a.m. ET.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES